Improved prescription of taohechengqi-tang alleviates D-galactosamine acute liver failure in rats

Table 2 Biochemistry and histopathology

Group	n	ALT (U/L)	AST (U/L)	TBiL (μmol/L)	ALB (g/L)	CHE (U/L)	PT (s)	Histopathological scores
Control	10	35.15 ± 6.01	151.61 ± 20.87	1.55 ± 0.43	35.25 ± 4.19	557.40 ± 43.23	13.60 ± 1.73	0
Model	20	441.10 ± 60.36a	887.80 ± 128.47a	38.04 ± 6.84a	23.67 ± 3.21a	343.92 ± 68.93a	31.80 ± 5.02a	3.69 ± 0.38a
SNMC	20	267.18 ± 41.45b	380.49 ± 55.38b	24.37 ± 4.03b	26.65 ± 4.50	378.50 ± 83.53	29.93 ± 3.83	2.78 ± 0.31b
IPTT	20	127.45 ± 25.33bc	264.04 ± 63.432bc	19.37 ± 3.26bc	30.22 ± 4.30bc	488.61 ± 76.41bc	23.78 ± 4.34bc	2.06 ± 0.40bc

^aP < 0.05 vs control group;

^bP < 0.05 vs group; and

^cP < 0.05 vs SNMC group. Control group: Negative control group; Model group: Injected with D-GalN; SNMC group: Injected with D-GalN and treated with SNMC; IPTT group: Injected with D-GalN and treated with modified Taohechengqi-tang.